Ligand · KJ8
KJ8 · N-[3-(4-{[(1S)-2-hydroxy-1-phenylethyl]amino}-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl]-N~3~,N~3~-dimethyl-beta-alaninamide
KJ8, N-[3-(4-{[(1S)-2-hydroxy-1-phenylethyl]amino}-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl]-N~3~,N~3~-dimethyl-beta-alaninamide (C31 H31 N5 O3, 521.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- KJ8
- Formula
- C31 H31 N5 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
KJ8 in 2 structures; the first of them:
- 4JQ8 · Crystal structure of EGFR kinase domain in complex with compound 4b · KJ8 A1001 · binds LEU694, GLY695, PHE699, VAL702, ALA719, ILE720, LYS721, MET742 and 12 more
- 4JQ8 · Crystal structure of EGFR kinase domain in complex with compound 4B · KJ8 A1001 · binds LEU694, GLY695, PHE699, VAL702, ALA719, ILE720, LYS721, MET742 and 12 more
Residues it binds most
LEU 2, ASP 2, GLY 2, MET 2, ALA 2, ARG 2, ASN 2, GLN 2, ILE 2, LYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.